|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 471/04 | (2013.01) |
| (11) | Number of the document | 3915984 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20740931.9 |
| Date of filing the European patent application | 2020-01-17 | |
| (97) | Date of publication of the European application | 2021-12-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2020/072582 |
| Date | 2020-01-17 |
| (87) | Number | WO 2020/147803 |
| Date | 2020-07-23 |
| (30) | Number | Date | Country code |
| 201910057056 | 2019-01-19 | CN | |
| 202010037085 | 2020-01-14 | CN |
| (72) |
SHI, Dongfang , CN
FU, Changjin , CN
GU, Jie , CN
ZHANG, Min , CN
GONG, Weiwei , CN
LI, Pengfei , CN
|
| (73) |
Jiangsu Atom Bioscience and
Pharmaceutical Co., Ltd. ,
Suite 401, Building C31, Biomedical Industry Park
218 Xinghu Street, Suzhou Industrial Park
China (Jiangsu) Pilot Free Trade Zone-Suzhou Area, Suzhou City, Jiangsu Province, 215123,
CN
|
| (54) | SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-ALPHA]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE |
| SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-ALPHA]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE |